News und Analysen
Why Is Everyone Talking About UnitedHealth Group Stock?
UnitedHealth (NYSE: UNH) stock is trading near its 52-week low.
*Stock prices used were the afternoon prices of Aug. 4, 2025. The video was published on Aug. 6, 2025.
Source Fool.c
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
Incoming patent cliffs regarding some of Pfizer's (NYSE: PFE) largest revenue streams have been pressuring the pharmaceutical stock. The price is down, but its dividend payout keeps rising. Last
If You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today
UnitedHealth Group (NYSE: UNH) has been in the news over the past several months, but not positively. Unfortunately, the CEO of its healthcare unit, Brian Thompson, was shot and killed late last
UnitedHealth Stock Investors: You Need to Know This Before Buying or Selling This Stock
UnitedHealth Group (NYSE: UNH) stock investors will want to digest this information before making the important decision to invest in or divest from this stock.
*Stock prices used were the
1 Reason to Buy Pfizer (PFE) Stock
I can actually think of multiple reasons to buy shares of Pfizer (NYSE: PFE) stock, but if I had to focus on only one, I'd choose its dividend. The stock's dividend yield was recently a whopping
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the Dip
Vertex Pharmaceuticals (NASDAQ: VRTX) reported its second-quarter results after the market closed on Monday. Its shares plunged more than 17% in early trading on Tuesday.
Were Vertex's Q2 results
Amgen (AMGN) Q2 Profit Jumps 21%
Amgen (NASDAQ:AMGN), a leading biotechnology company with a wide portfolio of innovative medicines, released its second-quarter 2025 results on August 5, 2025. The headline news was a double-digit
Why Shares of Pfizer Soared Today
Shares of the large pharmaceutical company Pfizer (NYSE: PFE) closed up over 5% today after a strong earnings report that included raising its full-year profit outlook for 2025.
In the second
UnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
Things are going from bad to worse for UnitedHealth Group (NYSE: UNH). Investors were already enduring a tough year in 2025, with the company facing myriad bits of bad news, including poor financial
GBTG Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, Aug. 5, 2025 at 1:00 p.m. ET
Chief Executive Officer — Paul Abbott
Source Fool.com
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today
Five years ago, the world was in the thick of the COVID-19 global pandemic, bringing Pfizer (NYSE: PFE) into the spotlight because of the role it played in developing the COVID-19 vaccine with its
1 Top Dividend Growth Stock to Buy and Hold Forever
There are many reasons to invest in dividend stocks. Companies that offer regular payouts tend to have strong underlying operations and generate consistent revenue and profits, making them excellent
Up 50% in 3 Months, Is This Stock Still a Buy?
Is this finally the year CRISPR Therapeutics (NASDAQ: CRSP) bounces back? The biotech has lagged the market in recent years, but shares are up 50% over the past three months and have climbed 42%
If You'd Invested $1,000 in Medtronic (MDT) Stock 5 Years Ago, Here's How Much You'd Have Today
What were you doing five years ago? Were you working from home due to the new pandemic? Watching Shakira and J. Lo perform at the Super Bowl? Perhaps you were buying some stocks. If you spent $1,000
Waters (WAT) Q2 Revenue Jumps 9%
Waters (NYSE:WAT), the analytical instruments and laboratory technology leader, released its Q2 2025 earnings on August 4, 2025. The company's results topped Wall Street estimates, reporting revenue
If You'd Invested $1,000 in AbbVie (ABBV) Stock 10 Years Ago, Here's How Much You'd Have Today
Think back to 10 years ago. The New England Patriots and their quarterback Tom Brady were accused of underinflating footballs. The Supreme Court affirmed same-sex marriage nationwide. And Apple
The 3 Things That Matter for Pfizer Now
Once a market darling during the early pandemic years, Pfizer (NYSE: PFE) has been on a straight southbound path for several years now. The company's shares are down by 50% since 2022.
Some
3 Dividend Stocks to Double Up on Right Now
If you are looking to buy some dividend stocks right now, you'll want to get to know Realty Income (NYSE: O), PepsiCo (NASDAQ: PEP), and Medtronic (NYSE: MDT). All three are reliable dividend payers
3 Reasons to Buy Medtronic Stock
Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has significantly lagged the market over this period, thanks to weak business
Why Is UnitedHealth Stock Falling, and Is It a Buying Opportunity?
UnitedHealth (NYSE: UNH) revised its annual targets, disappointing stock market investors.
*Stock prices used were the afternoon prices of July 28, 2025. The video was published on July 30, 2025.
3 Unstoppable Stocks to Buy in August
The "it" factor. Some stocks have it. Other stocks don't. But the ones that do can be virtually unstoppable.
Three Motley Fool contributors believe they've found such unstoppable stocks with the
Regeneron (REGN) Q2 EPS Jumps 53%
Regeneron (NASDAQ:REGN), a leading biotechnology firm known for its work in immunology and ophthalmology, reported Q2 2025 earnings on August 1, 2025. The headline news: the company posted Non-GAAP
Stryker (SYK) Q2 Revenue Jumps 11%
Stryker (NYSE:SYK), a leading global medical technology company, reported financial results on July 31, 2025. The company delivered several key beats: Net sales (GAAP) reached $6.0 billion, topping
Why AbbVie Stock Flew Higher on Friday
A bellwether stock in the lately rather up-and-down pharmaceutical sector, AbbVie (NYSE: ABBV) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in
Cigna (CI) Q2 Revenue Jumps 11%
Cigna Group (NYSE:CI), a global health services company offering integrated medical, pharmacy, and specialty care solutions, released its second-quarter earnings on July 31, 2025. The company